Federal Register / Vol. 80, No. 49 / Friday, March 13, 2015 / Notices 13383 

MD 20993–0002, 301–796–8930, email: 

John.Weiner@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In the Federal Register of January 27, 

2015 (80 FR 4280), FDA published a 

notice with a 60-day comment period to 

request comments on the draft guidance 

for industry and FDA staff entitled 

‘‘Current Good Manufacturing Practice 

Requirements for Combination 

Products.’’ 

The Agency received a request for a 

30-day extension of the comment period 

for the draft guidance. The request 

conveyed concern that the current 60- 

day comment period does not allow 

sufficient time to respond. FDA has 

considered the request and is extending 

the comment period for the draft 

guidance for 30 days, until April 29, 

2015. The Agency believes that a 30-day 

extension allows adequate time for 

interested persons to submit comments 

without significantly delaying further 

FDA action on this guidance document. 

II. Comments 

Interested persons may submit either 

electronic comments regarding this 

document to http://www.regulations.gov 

or written comments to the Division of 

Dockets Management (see ADDRESSES). It 

is only necessary to send one set of 

comments. Identify comments with the 

docket number found in brackets in the 

heading of this document. Received 

comments may be seen in the Division 

of Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday, and 

will be posted to the docket at http://

www.regulations.gov. 

III. Electronic Access 

Persons with access to the Internet 

may obtain the document at either 

http://www.fda.gov/Regulatory

Information/Guidances/ucm126198.htm 

or http://www.regulations.gov. 

Dated: March 9, 2015. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2015–05674 Filed 3–12–15; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Advisory Committee for Women’s 

Services (ACWS); Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given of a meeting of 

the Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

Advisory Committee for Women’s 

Services (ACWS) on April 15, 2015. 

The meeting will include discussions 

on lesbian, bisexual and transgender 

issues; high-risk/high-need girls and 

young women; supporting women in coed settings—core competencies, 

practices and strategies; SAMHSA’s 

Pregnant and Post-Partum Women Grant 

Program; and a conversation with the 

SAMHSA Administrator. 

The meeting is open to the public and 

will be held at SAMHSA, 1 Choke 

Cherry Road, Rockville, MD 20850, in 

the Rock Creek Conference Room. 

Attendance by the public will be limited 

to space available. Interested persons 

may present data, information, or views, 

orally or in writing, on issues pending 

before the Committee. Written 

submissions should be forwarded to the 

contact person (below) on or before 

April 7, 2015. Oral presentations from 

the public will be scheduled at the 

conclusion of the meeting. Individuals 

interested in making oral presentations 

are encouraged to notify the contact 

person on or before April 7, 2015. Five 

minutes will be allotted for each 

presentation. 

The meeting may be accesed via 

telephone. To attend on site, obtain the 

call-in number and access code, submit 

written or brief oral comments, or 

request special accommodations for 

persons with disabilities, please register 

on-line at: http://nac.samhsa.gov/

Registration/meetingsRegistration.aspx, 

or communicate with SAMHSA’s 

Designated Federal Officer, Ms. Nadine 

Benton (see contact information below). 

Substantive meeting information and 

a roster of Committee members may be 

obtained either by accessing the 

SAMHSA Committees’ Web site at: 

http://www.samhsa.gov/about-us/ 

advisory-councils/advisory-committeewomen%E2%80%99s-services-awcs, or 

by contacting Ms. Benton. 

Committee Name: Substance Abuse 

and Mental Health Services 

Administration Advisory Committee for 

Women’s Services (ACWS). 

Date/Time/Type: Wednesday, April 

15, 2015, from 9:00 a.m. to 5:15 p.m. 

EDT: Open. 

Place: SAMHSA, 1 Choke Cherry 

Road, Rock Creek Conference Room, 

Rockville, Maryland 20850. 

Contact: Nadine Benton, Designated 

Federal Official, SAMHSA’s Advisory 

Committee for Women’s Services, 1 

Choke Cherry Road, Rockville, 

Maryland 20857 (mail), Telephone: 

(240) 276–0127, Fax: (240) 276–2252, 

Email: nadine.benton@samhsa.hhs.gov. 

Summer King, 

Statistician, SAMHSA. 

[FR Doc. 2015–05816 Filed 3–12–15; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Center for Substance Abuse 

Prevention; Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given that the 

Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

Center for Substance Abuse Prevention 

(CSAP) Drug Testing Advisory Board 

(DTAB) will meet via web conference on 

April 9, 2015, from 10:00 a.m. to 3:30 

p.m. E.D.T. 

The Board will meet in closed session 

to discuss confidential research data, as 

well as proposed revisions to the 

Mandatory Guidelines for Federal 

Workplace Drug Testing Programs. 

Therefore, this meeting is closed to the 

public as determined by the 

Administrator, SAMHSA, in accordance 

with 5 U.S.C. 552b(c)(4), 5 U.S.C. 

552b(c)(9)(B), and 5 U.S.C. App. 2, 

Section 10(d). 

Meeting information and a roster of 

DTAB members may be obtained by 

accessing the SAMHSA Advisory 

Committees Web site, http://www.

samhsa.gov/about-us/advisory-councils/

drug-testing-advisory-board-dtab, or by 

contacting Dr. Cook. 

Committee Name: Substance Abuse and 

Mental Health Services Administration’s 

Center for Substance Abuse Prevention Drug 

Testing Advisory Board. 

Dates/Time/Type: April 9, 2015, from 

10:00 a.m. to 3:30 p.m. E.D.T.: CLOSED. 

Place: SAMHSA Building, 1 Choke Cherry 

Road, Rockville, Maryland 20850. 

Contact: Janine Denis Cook, Ph.D., 

Designated Federal Official, CSAP Drug 

Testing Advisory Board, 1 Choke Cherry 

Road, Room 7–1043, Rockville, Maryland 

20857, Telephone: 240–276–2600, Fax: 240– 

276–2610, Email: janine.cook@

samhsa.hhs.gov. 

Janine Denis Cook, 

Designated Federal Official, DTAB, Division 

of Workplace Programs, Center for Substance 

Abuse Prevention, Substance Abuse and 

Mental Health Services Administration. 

[FR Doc. 2015–05749 Filed 3–12–15; 8:45 am] 

BILLING CODE 4162–20–P 

mstockstill on DSK4VPTVN1PROD with NOTICES